Enspire DBS Therapy, Inc.
PrivateLast Round
Series B
Extension
Jan 13, 2026
Total Funding Raised
$30.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Enspire DBS Therapy, Inc. is a medical device company developing an implantable neuromodulation therapy using deep brain stimulation to restore motor function in stroke survivors.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enspire DBS Therapy, Inc. Comparables
Compare Enspire DBS Therapy, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Reach Neuro, Inc. | 83% | |
| Mobia Medical | 82% | |
| Epia Neuro | 73% |
Enspire DBS Therapy, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 13, 2026 | ||||
| Series B | Aug 1, 2023 | ||||
| Early Funding | Dec 4, 2016 |
Enspire DBS Therapy, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cleveland Clinic Ventures | Series B, Series B Extension |
| Genesys Capital | Series B Extension |
| JobsOhio Ventures | Series B Extension, Series B |
| JobsOhio | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 86% MoM.
- Jan 13, 2026
$10.3M round led by Genesys Capital.
Enspire DBS Therapy, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Enspire DBS Therapy, Inc.'s valuation, stock price, and market status.
Is Enspire DBS Therapy, Inc. a public or private company?
Enspire DBS Therapy, Inc. is a private company.
What is the current stock price of Enspire DBS Therapy, Inc.?
Enspire DBS Therapy, Inc. is a private company, so its shares have no public market price. Caplight tracks Enspire DBS Therapy, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enspire DBS Therapy, Inc. worth (valuation)?
Valuation information for Enspire DBS Therapy, Inc. is not publicly available.
Can I buy Enspire DBS Therapy, Inc. stock?
Enspire DBS Therapy, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enspire DBS Therapy, Inc.'s last funding round?
Enspire DBS Therapy, Inc.'s most recent funding round was Series B Extension on January 13, 2026.
Who are the main investors in Enspire DBS Therapy, Inc.?
Key investors in Enspire DBS Therapy, Inc. include Cleveland Clinic Ventures, Genesys Capital.
Will Enspire DBS Therapy, Inc. IPO soon?
No public IPO plans have been announced for Enspire DBS Therapy, Inc..
How can I track Enspire DBS Therapy, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Enspire DBS Therapy, Inc.'s shares on secondary markets.